B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics.
Ann Rheum Dis
; 81(1): 143-145, 2022 01.
Article
en En
| MEDLINE
| ID: mdl-34556483
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Artritis
/
Productos Biológicos
/
Antirreumáticos
/
COVID-19
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Ann Rheum Dis
Año:
2022
Tipo del documento:
Article